{
  "Variants Include": [
    {
      "Gene": "MAPT",
      "variants": [
        {
          "HGVS": "NM_001130309.2:c.1166G>A",
          "cDNA Change": {
            "transcript": "NM_001130309.2",
            "ref": "G",
            "alt": "A",
            "position": "1166"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "389"
          },
          "Description in input context": "A G to A substitution at nucleotide 1166 results in the substitution of alanine for threonine at position 389 (p.Thr389Ala)."
        },
        {
          "HGVS": "NM_001130309.2:c.1233G>C",
          "cDNA Change": {
            "transcript": "NM_001130309.2",
            "ref": "G",
            "alt": "C",
            "position": "1233"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "C",
            "position": "411"
          },
          "Description in input context": "A G to C substitution at nucleotide 1233 results in the substitution of valine for proline at position 411 (p.Pro411Val)."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Frontotemporal Dementia",
    "MONDO": "MONDO:0000760"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiments were performed using the HEK293 cell line and were cultured as previously described."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130309.2:c.1166G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Protein levels were markedly reduced in samples carrying the p.Thr389Ala variant."
        },
        {
          "Variant": "NM_001130309.2:c.1233G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Protein levels were slightly reduced in samples carrying the p.Pro411Val variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were conducted."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type MAPT cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to determine statistical significance."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}